Drug intelligence / Profile preview

Dihydroxyacetone

Development stage
Unknown
Modality
Small Molecules
Administration
Topical
01

Overview

Dihydroxyacetone is a simple ketotriose monosaccharide (C3H6O3) and the only ketose sugar with three carbon atoms. It is primarily used as the active ingredient in sunless tanning products, where it reacts with amino acids in the stratum corneum of the skin via a Maillard reaction to form brown melanoidins that mimic a tan[3][4][5][6]. This pigmentation occurs without ultraviolet light exposure and typically appears within hours of topical application, lasting several days. Dihydroxyacetone can also be used experimentally as an additive in blood preservation solutions to maintain 2,3-diphosphoglycerate levels[2]. In biochemistry, its phosphorylated form (dihydroxyacetone phosphate) is an intermediate in glycolysis and fructose metabolism[4][6]. Commercially produced by microbial fermentation of glycerol or derived from plant sources such as sugar beets and cane[4][6], dihydroxyacetone is considered safe for most people when used topically but may cause irritation or allergic reactions in sensitive individuals.

Brand names
ChromelinChromelin Complexion Blender
Other names
1,3-dihydroxypropan-2-oneglycerone
02

Targets

Primary amino groups on stratum corneum proteins

Beyond the preview

Go deeper on Dihydroxyacetone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dihydroxyacetone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call